Search research articles
Contact Us
Filters
Showing results (81-90 of 84) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 84 results.
Acta Neuropathologica
|
May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch, Rene Schmidt, Marc Remke, et al.
BMJ Open
|
October 21, 2018
Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia
Ana Kowark, Christian Adam, Jörg Ahrens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
André Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.
Nature
|
October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer, Falk Hertwig, Frederik Roels, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 84) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 84 results.
Acta Neuropathologica
|
May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch, Rene Schmidt, Marc Remke, et al.
BMJ Open
|
October 21, 2018
Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia
Ana Kowark, Christian Adam, Jörg Ahrens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
André Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.
Nature
|
October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer, Falk Hertwig, Frederik Roels, et al.
Page
of 9